. Stimulation of 5-HT 2 receptors in prefrontal pyramidal neurons inhibits Ca v 1.2 L-type Ca 2ϩ currents via a PLC␤/ IP3/calcineurin signaling cascade. J Neurophysiol 87: 2490 -2504, 2002; 10.1152/jn.00843.2001. There is growing evidence linking alterations in serotonergic signaling in the prefrontal cortex to the etiology of schizophrenia. Prefrontal pyramidal neurons are richly innervated by serotonergic fibers and express high levels of serotonergic 5-HT 2 -class receptors. It is unclear, however, how activation of these receptors modulates cellular activity. To help fill this gap, whole cell voltage-clamp and single-cell RT-PCR studies of acutely isolated layer V-VI prefrontal pyramidal neurons were undertaken. The vast majority (Ͼ80%) of these neurons had detectable levels of 5-HT 2A or 5-HT 2C receptor mRNA. Bath application of 5-HT 2 agonists inhibited voltage-dependent Ca 2ϩ channel currents. L-type Ca 2ϩ channels were a particularly prominent target of this signaling pathway. The L-type channel modulation was blocked by disruption of G ␣q signaling or by inhibition of phospholipase C␤. Antagonism of intracellular inositol trisphosphate signaling, chelation of intracellular Ca 2ϩ , or depletion of intracellular Ca 2ϩ stores also blocked this modulation. Inhibition of the Ca 2ϩ -dependent phosphatase calcineurin prevented receptor-mediated modulation of L-type currents. Last, the 5-HT 2 receptor modulation was robustly expressed in neurons from Ca v 1.3 knockout mice. These findings argue that 5-HT 2 receptors couple through G ␣q proteins to trigger a phospholipase C␤/inositol trisphosphate signaling cascade resulting in the mobilization of intracellular Ca 2ϩ , activation of calcineurin, and inhibition of Ca v 1.2 L-type Ca 2ϩ currents. This modulation and its blockade by atypical neuroleptics could have wide-ranging effects on synaptic integration and long-term gene expression in deep-layer prefrontal pyramidal neurons.
There is growing evidence linking alterations in serotonergic signaling in the prefrontal cortex to the etiology of schizophrenia. Prefrontal pyramidal neurons are richly innervated by serotonergic fibers and express high levels of serotonergic 5-HT 2 -class receptors. It is unclear, however, how activation of these receptors modulates cellular activity. To help fill this gap, whole cell voltage-clamp and single-cell RT-PCR studies of acutely isolated layer V-VI prefrontal pyramidal neurons were undertaken. The vast majority (Ͼ80%) of these neurons had detectable levels of 5-HT 2A or 5-HT 2C receptor mRNA. Bath application of 5-HT 2 agonists inhibited voltage-dependent Ca 2ϩ channel currents. L-type Ca 2ϩ channels were a particularly prominent target of this signaling pathway. The L-type channel modulation was blocked by disruption of G ␣q signaling or by inhibition of phospholipase C␤. Antagonism of intracellular inositol trisphosphate signaling, chelation of intracellular Ca 2ϩ , or depletion of intracellular Ca 2ϩ stores also blocked this modulation. Inhibition of the Ca 2ϩ -dependent phosphatase calcineurin prevented receptor-mediated modulation of L-type currents. Last, the 5-HT 2 receptor modulation was robustly expressed in neurons from Ca v 1.3 knockout mice. These findings argue that 5-HT 2 receptors couple through G ␣q proteins to trigger a phospholipase C␤/inositol trisphosphate signaling cascade resulting in the mobilization of intracellular Ca 2ϩ , activation of calcineurin, and inhibition of Ca v 1.2 L-type Ca 2ϩ currents. This modulation and its blockade by atypical neuroleptics could have wide-ranging effects on synaptic integration and long-term gene expression in deep-layer prefrontal pyramidal neurons.
I N T R O D U C T I O N
Schizophrenia afflicts one-half to one percent of the world's population, including as many as two million Americans. There are several lines of evidence implicating the prefrontal cortex (PFC) in this disorder. Perhaps the most convincing evidence is the linkage of the PFC to many executive functions disrupted in people with schizophrenia, including working memory, abstract thinking, attention, and language coherency (Goldman-Rakic 1991; Goldman-Rakic and Selemon 1997; Levin 1984) . These and other symptoms are alleviated in many patients by atypical neuroleptic drugs that share a high affinity for serotonin 5-HT 2 receptors (Leysen et al. 1994; Meltzer et al. 1989; Schotte et al. 1993 Schotte et al. , 1996 . The PFC receives robust serotonergic projections from the raphe nuclei (Lindvall and Björklund 1984) and expresses high levels of 5-HT 2 receptor, particularly in layer V prefrontal pyramidal neurons (PPNs) (Pazos et al. 1985 (Pazos et al. , 1987 . In these deep-layer PPNs, 5-HT 2A receptors are enriched in the apical dendrites that extend into more superficial layers (Goldman-Rakic 1999; Willins et al. 1997) .
How activation of these PFC 5-HT 2 receptors modulates the excitability of deep-layer (V-VI) PPNs is controversial. 5-HT 2 receptor activation depolarizes rat layer V PPNs (Araneda and Andrade 1991), rat cingulate cortex pyramidal neurons (Tanaka and North 1993) , and human layer III neocortical neurons (Newberry et al. 1999) . 5-HT 2 receptor activation also increases excitatory postsynaptic currents in rat layer V PPNs Marek 1997, 1999) . In contrast, 5-HT 2 receptor activation inhibits N-methyl-D-aspartate (NMDA) receptormediated currents (Arvanov and Wang 1998; Arvanov et al. 1999a; Arvanov et al. 1999b ) and spontaneous activity (Bergqvist et al. 1999; Godbout et al. 1991; Mantz et al. 1990 ). Furthermore, 5-HT 2 receptor blockade with atypical neuroleptics induces PFC immediate early genes (Robertson and Fibiger 1996; Robertson et al. 1994; Wiesel et al. 1994) . These seemingly disparate findings may have a unifying explanation, but if so, it will only come from a better understanding of the way in which 5-HT 2 receptor signaling cascades modulate voltage-dependent ion channels.
In an attempt to isolate the postsynaptic mechanisms by which 5-HT 2 receptors modulate excitability, pyramidal neurons were acutely isolated from the deeper layers of rat prelimbic and infralimbic cortex. Because voltage-dependent Ca 2ϩ channels are important targets of monoamine receptors in other cell types (Cepeda et al. 1998; Hernandez-Lopez et al. 2000; Surmeier et al. 1995) , our initial studies focused on the ability of 5-HT 2 receptors to modulate whole cell Ca 2ϩ channel
Whole cell recording
Whole cell recordings were made using standard techniques (Hamill et al. 1981) . Electrodes were made by pulling 7052 glass (A-M Systems, Carlsborg, WA) on a Sutter P-97 Flaming/Brown micropipette puller (Sutter Instrument, Novato, CA) and fire-polished with a MF-83 (Narishige Scientific Instrument Lab, Tokyo). The internal pipette solution contained the following (in mM): 190 N-methyl-Dglucamine, 4 MgCl 2 , 2 Na 2 ATP, 0.2 Na 2 GTP (Boehringer Mannheim, Indianapolis, IN), 12 phosphocreatine, 0.1 leupeptin (Bachem, Torrance, CA), and 40 HEPES (pH ϭ 7.2 with H 2 SO 4 , 270 mosM/1). Some internal solutions also contained 15 mM bis-(o-aminophenoxy)-N,N,NЈ,NЈ-tetraacetic acid (BAPTA, Molecular Probes, Eugene, OR). The external recording solution contained the following (in mM): 130 tetraethylamonium (TEA) chloride, 1 MgCl 2 , 2 BaCl 2 , 10 glucose, 10 HEPES, and 0.001 tetrodotoxin (TTX; pH ϭ 7.4 with TEA-OH, 300 mosM/1). In some recordings, 135 mM NaCl and 20 mM CsCl replaced TEA-Cl. The external recording solutions were locally applied to the neurons through an array of glass capillary tubes Ϸ500 M in diameter. The flow of external solutions was gravity-fed controlled by a system of electronic valves (Lee, Essex, CT). Exchanging the external solution was completed in Ϸ1 s by altering the position of the array with a PMC200-P2 motion controller and an 850B high-speed actuator (Newport, Irvine, CA). The valve perfusion system and the Newport motion controller were synchronously driven by a PC running Labview software (Version 4.0.1, National Instruments, Austin, TX).
Depending on their solubility, the drugs and toxins used in the experiments were first dissolved in either H 2 O or dimethyl sulfoxide (DMSO) to make stock solutions at concentrations of 1,000 to 10,000ϫ. When drugs were dissolved in DMSO, equivalent amounts were added to the external control solutions. If the manufacturer indicated the drug was stable in solution, the stocks may have been frozen for Յ1 wk before use; otherwise, all were freshly prepared on the day of use. The 5-HT 2 agonists (Ϯ)-2,5-dimethoxy-4-iodoamphetamine hydrochloride (DOI), and ␣-methyl-5-hydroxytryptamine maleate (␣-m-5-HT) and 5-HT 1 agonist (ϩ)-8-hydroxy-2-(dipropylamino)-tetralin (R)-(ϩ)-2-dipropylamino-8-hydroxy-1,2,3,4-tetrahydronaphthalene (8-OH-DPAT), which may have some small potential to oxidize, were dissolved in 1% sodium metabisulfite stock solution. All three were obtained from Sigma. The final concentration of metabisulfite (0.001%) was never seen to affect baseline currents. Other drugs used include ritanserin, ketanserin, risperidone, clozapine, LY-53,857, (Ϯ)-Bay K 8644, chelerythrine chloride, U-73122, U-73343, xestospongin C, thapsigargin, calcineurin autoinhibitory peptide, FK-506 (Calbiochem, San Diego, CA), nifedipine (Alexis, San Diego, CA), -conotoxin GVIA (CgTx; Bachem), and -agatoxin TK (AgTx; Peninsula Laboratories, San Carlos, CA). Cytochrome C (0.05%) was added to AgTx-containing solutions. To control for any effects of cytochrome C, it was included at equal concentrations in all external solutions in experiments using AgTx. The guanine nucleotide-binding protein peptide (G q peptide) was designed to mimic C-terminal residues 343-353 of the alpha subunit (GenBank Accession No. P82471). The sequence was LQLNLKEYNLV.
Electrophysiological recordings were obtained using an Axopatch 200B amplifier (Axon Instruments, Foster City, CA). Data were acquired though an ITC-16 interface linked to an Apple computer running Pulse and Pulse Fit software (Version 8.1, Instrutech, Elmont, NY). Pyramidal neurons were voltage clamped at room temperature using patch electrodes with series resistances of 1.5-2.0 M⍀. After G⍀ seal formation and rupture, series resistance was compensated 75% and periodically monitored. A sample of pyramidal neurons showed a mean whole cell capacitance of 16.3 Ϯ 0.6pF (n ϭ 54). Pyramidal neurons were selected by their morphology and all had a large apical dendrite. Voltage control was determined by examining the decay of the tail currents after depolarization from 80 to 0 mV. If, under control conditions, the tails did not decay smoothly and completely within 10 ms, the neurons were discarded. Current trace data were analyzed with Igor Pro software (Version 3.12, WaveMetrics, Lake Oswego, OR).
scRT-PCR
scRT-PCR was performed using protocols previously described (Baranauskas et al. 1999; Tkatch et al. 2000) . Individual neurons were patched and aspirated into micropipettes while being continuously perfused by the control solution. The micropipettes contained Ϸ1 l of diethylpyrocarbonate (DEPC)-treated water. To minimize RNase activity, the micropipettes were autoclaved, sterile gloves were worn at all times during the procedures, and the external control solutions were prepared with essentially RNase-free water. After aspirating the cell into the tip of the micropipette, the tip was broken off and the contents expelled into an Eppendorf tube containing DEPC-treated water (1.6 l), RNasin (0.7 l, 40U/l), BSA (0.7 l), and random hexamers (2 l, 50 ng/l; Promega, Madison, WI).
Single-stranded cDNA was generated by reverse transcription. First, the neuron-containing mixture was heated to 70°C for 10 min to denature the nucleic acids, then cooled on ice for Ն1 min. To this mixture was added 10ϫ PCR buffer (2 l), MgCl 2 (2 l, 25 mM), DTT (2 l, 0.1 M), dNTPs (1 l, 10 mM each; Promega), and DEPC-treated water to bring the final volume to 20 l. The reaction mixtures were then heated to 42°C, at which point SuperScript II (1 l, 200 U/l; Life Technologies, Grand Island, NY) was added. Next, these RT reactions were run at 42°C for 50 min. The temperature was then increased to 70°C for 15 min to terminate the reactions. Finally, to eliminate any residual RNA, RNase H (0.5 l, 2 U/l; Life Technologies) was added and the reaction mixtures were held at 37°C for 20 min.
PCR amplification of the resulting cDNA was done by standard methods using a thermal cycler (P-200, MJ Research, Watertown, MA). The PCR reaction was carried out using 4 l of cDNA template, 10ϫ PCR buffer (2.6 l), MgCl2 (2.6 l, 25 mM), dNTPs (1 l, 10 mM), primers (1.5 l each, 20 M), and DEPC-treated water for a final volume of 30 l. Taq polymerase (0.5 l, 5 U/l; Promega) was added immediately before the first cycling step. "Touch-down" protocols were implemented for more efficient amplification of singlecell cDNA. This was done by modifying a standard 45-cycle PCR protocol in the following way: first, 35 cycles were run at the optimal annealing temperature for each primer set, then the annealing temperature was decreased by 1°C for two cycles-five times-for a total of 45 cycles. The optimal annealing temperatures for the primers were determined using Oligo software (Version 6.4, National Biosciences, Plymouth, MN).
The primer sequences for Ca 2ϩ -and calmodulin-dependent kinase type-II (CaMKII) and 5-HT 2A and 5-HT 2C have been published (Vysokanov et al. 1998 ) and have predicted product lengths of 354, 465, and 545 bp respectively. The primers for PLC␤1-4 have also been published (Hernandez-Lopez et al. 2000) and have predicted lengths of 253, 547, and 420 bp for PLC␤1-3, respectively, with PLC␤4 having two products with predicted lengths of 209 and 246 bp.
In each set of single-cell reactions, both positive and negative controls were performed. Positive controls were run with pooled PFC cDNA. To control for the possible contribution of genomic DNA in the single-cell reactions, reverse transcriptase was omitted from one of the samples in each set. To control for cDNA contamination of reagents, the cell was omitted from one reaction mixture in each set. These controls were consistently negative.
Statistical procedures
Statistical analyses were performed with Systat software (Version 5.2, Evanston, IL). Significant differences between small unmatched samples were determined using Kruskal-Wallis one-way ANOVA. Box plots were generated for graphic presentation of the results. Sample statistics are given as medians because they provide the most robust estimate of central tendency. This feature is important in cases where small sample sizes do not allow the properties of their underlying sampling distributions to be determined.
R E S U L T S
PPNs express serotonin 5-HT 2A -and 5-HT 2C -class mRNA Layers V and VI were dissected from rat prelimbic and infralimbic cortex and the PPNs were acutely isolated (Fig.  1A ). These neurons have one large apical dendrite and several finer basal dendrites that can be preserved with careful dissociation (Fig. 1B) . As expected from previous studies (Pompeiano et al. 1994; Wright et al. 1995) , RT-PCR analysis of pooled PFC RNA revealed the presence of 5-HT 2A , 5-HT 2C , and calmodulin-dependent protein kinase II (CaMKII) mRNAs (Fig. 1C, top left) . To determine the cellular expression of 5-HT 2 -class mRNAs, scRT-PCR experiments were conducted on large, visually identified pyramidal neurons (Fig. 1C, top, right) . The identification of these pyramidal neurons was confirmed by their expression of CaMKII mRNA (Benson et al. 1992 ). This nonquantitative profiling detected 5-HT 2A mRNA in 67% of all PPNs sampled (n ϭ 18). Ten of these neurons were also examined for their expression of 5-HT 2C mRNA; 5-HT 2C was detected in one of the neurons in this sample (this neuron did not have detectable levels of 5-HT 2A mRNA). These data are summarized in the bar graph shown in Fig. 1C , bottom. The simplest interpretation of these results is that the majority of layer V-VI PPNs express 5-HT 2A receptor mRNA.
PPNs have L-, N-, P/Q-, and R-type Ca 2ϩ currents
Whole cell voltage-clamp recordings were made from PPNs using techniques that allowed the isolation of currents through voltage-dependent Ca 2ϩ channels (Bargas et al. 1994) . To determine the contribution of N-, P/Q-, L-, and R-type currents, channel-specific blockers were applied while activating currents with depolarizing voltage steps. Currents were evoked every 5 s to minimize rundown. Blockers of L-type current (nifedipine, 5 M), N-type current (-CgTx GVIA, 1 M), and P/Q-type current (-AgTx TK, 1 M) consistently blocked a portion of the whole cell current ( Fig. 2A) . The current that remained after application of nifedipine, -CgTx GVIA, and -AgTx TK was operationally defined as R-type current. The R-type current was completely blocked by cadmium (200 M). Figure 2B shows individual current traces taken at each stage in the addition of the channel blockers. The percent contribution of each high-voltage-activated (HVA) Ca 2ϩ current type was calculated by subtraction. The median percent L-type current was 21%, N-type was 18%, P/Q-type was 41%, and R-type was 25%. Kruskal-Wallis ANOVA revealed that PPNs display significantly more P/Q-type current than L-, N-, or R-type current (P Ͻ 0.01, n ϭ 4; Fig. 2C ).
5-HT 2 receptor stimulation reduces L-type Ca 2ϩ currents
An initial set of experiments revealed that the 5-HT 2 agonist DOI consistently reduced whole cell Ca 2ϩ channel currents (data not shown) and L-type currents in particular. L-type currents were isolated by applying nifedipine (5 M) and subtracting the resulting currents from those evoked in its absence. Previous work with cortical pyramidal neurons (Foehring et al. 2000; Furukawa et al. 1999 ) and heterologous expression systems (Furukawa et al. 1999) had shown that this concentration of nifedipine has no detectable effect on N-, P/Q-, or R-type HVA currents using similar voltage protocols. To determine the effect of 5-HT 2 receptor stimulation on L-type current, recordings were made in the presence and absence of DOI (10 M) and ␣-m-5-HT (10 M; Fig. 3A ).
Nifedipine-subtracted traces show that both DOI (Fig. 3B ) and ␣-m-5-HT inhibited peak L-type current. The median percent inhibition by 5-HT 2 agonist was 24% for DOI and 20% for ␣-m-5-HT. The box plot of the data shows no significant difference in inhibition of peak L-type HVA current by DOI or ␣-m-5-HT at nominally saturating equimolar concentrations (10 M) (Kruskal-Wallis ANOVA, n ϭ 7; Fig. 3C) .
A second way to assess modulation of L-type current is to use the L-type channel agonist Bay K 8644 (1 M) to enhance L-type currents and slow their deactivation (Hernandez-Lopez et al. 2000; Howe and Surmeier 1995; Tsien et al. 1986 ). As shown in Fig. 4A , Bay K 8644 greatly slows the deactivation of L-type channels and effectively isolates L-type channel tail currents late in the response to a repolarizing step. Plotting the inverted tail currents on a semi-log scale makes the biexponential decay in the presence of Bay K 8644 apparent and allows the determination of a time in the decay when the contribution of non-L-type currents should be minimal (more than Ϸ2-3 ms, Fig. 4B ). This temporal separation was used to assess the impact of neuromodulators on L-type channel function. Tail current amplitude (at 6 ms following the repolarizing step) is plotted as a function of time in Fig. 4C ; the plot shows the enhancement of tail currents by Bay K 8644 and their reversible inhibition by DOI (10 M). Similar results were seen in nearly every PPN tested (92%, n ϭ 59). Representative voltage-clamp current records taken before, during, and after DOI application are shown in Fig. 4D . Records taken before the application of Bay K 8644 also illustrate the change induced in current amplitude and kinetics. The point in the tail current decay that was used for measurement is identified by a gray bar in Fig. 4D .
In all of the neurons chosen for analysis, tail currents in the presence and absence of DOI decayed smoothly back to baseline-indicating that DOI had not altered current amplitudes by influencing voltage-clamp quality. But to provide a more rigorous test of this possibility, tail current kinetics were estimated by fitting with a biexponential function. If the quality of the voltage control fluctuated, it should be reflected in altered decay kinetics. However, in all of the cases examined (n ϭ 6), the deactivation time constants in the absence of DOI were indistinguishable from those in the presence of DOI. In particular, the amplitude of the slowly deactivating current was diminished by DOI application, but the decay time constant was unaltered (Fig. 4E) . Furthermore, there was excellent concordance between the percent inhibition of the slowly deactivating component estimated by curve fitting and that estimated by simply measuring the tail current amplitude at 6 ms (no more than 4% difference between the 2 measures in the same cell). As a consequence, the DOI effects on tail currents in subsequent experiments were determined by the simple amplitude measurement shown in Fig. 4D . These experiments are summarized in box plot format in Fig. 4F . The median inhibition of L-type tail current by DOI was 19.5 and 20% by ␣-m-5-HT. These effects were not significantly different (Kruskal-Wallis ANOVA, P Ͼ 0.05, n ϭ 10). In contrast to the effects of the 5-HT 2 receptor agonists, application of the 5-HT 1 receptor-preferring agonist, 8-OH-DPAT, failed to significantly modulate Bay K 8644-enhanced L-type tail currents. As reported previously in sensorimotor cortex pyramidal neurons, 8-OH-DPAT reduced whole cell Ca 2ϩ channel currents (Foehring 1996) . A plot of peak current evoked by a slowly repeated test step to Ϫ10 mV is shown in Fig. 5A (E). 8-OH-DPAT at both 1 and 10 M reduced the amplitude of these currents as did subsequent application of DOI. However, the slow tail currents were not reduced by either concentration of 8-OH-DPAT, whereas application of DOI resulted in a reversible modulation (Fig. 5A, F) . Representative current traces are shown in Fig. 5B . In a sample of seven pyramidal neurons, the median 8-OH-DPAT (10 M) reduction of currents evoked by a step to Ϫ10 mV was 9%, but the reduction in slow tail current amplitude was not significantly different from control solution changes (median reduction ϭ 3%).
To provide an additional verification of 5-HT 2 receptor mediation of the DOI and ␣-m-5-HT effects, several 5-HT 2 receptor antagonists were examined. Ritanserin, ketanserin, LY-53,857, clozapine, and risperidone were tested. All of the antagonists inhibited HVA current at low micromolar concentrations in the absence of agonist (data not shown). At 10 M, ritanserin reduced currents dramatically (median ϭ76%, n ϭ 3), whereas ketanserin (20%, n ϭ 6), clozapine (19%, n ϭ 3), and LY-53,857 (16%, n ϭ 6) had smaller but significant effects. Risperidone (10 M) only modestly reduced currents (median ϭ 5%, n ϭ 3). This pattern of effects is similar to that reported by Sah and Bean in response to neuroleptics (Sah and Bean 1994) . As described in these earlier studies, a direct interaction of the antagonists with the Ca 2ϩ channel pore was tested by examining unblocking kinetics in the presence and absence of the pore blocker Cd 2ϩ (Chow 1991; Donaldson and Beam 1983) . If Cd 2ϩ and the receptor antagonist bind within the pore to block channel currents, then allowing Cd 2ϩ access to its binding site first should prevent the antagonist from gaining access to its binding site, leading to rapid current recovery kinetics resembling those of Cd 2ϩ alone. Ketanserin and ritanserin had slow enough recovery kinetics relative to those of Cd 2ϩ to make this type of analysis feasible. Kitanserin recovery kinetics were dramatically accelerated by preexposure to Cd 2ϩ (200 M), changing from a median of 9.5 to 4.2 s (n ϭ 7)-a rate that was not different from that seen with Cd 2ϩ alone (median ϭ 3.7 s, n ϭ 14). Washing kinetics following exposure to ritanserin were also accelerated by preexposure to Cd 2ϩ . However, the recovery occurred with a fast phase (resembling that of Cd 2ϩ ) and a slower phase. The time constant of the slower phase (median ϭ 26 s, n ϭ 7) was much faster than the mono-exponential recovery seen in the absence of Cd 2ϩ (median ϭ 45 s, n ϭ 3). These results are consistent with the hypothesis that both ketanserin and ritanserin act as Ca 2ϩ channel pore blockers in a subset of Ca 2ϩ channels. Further studies will be necessary to fully characterize this phenomenon, but it clearly makes the use of these antagonists problematic in the analysis of 5-HT 2 receptor modulation of Ca 2ϩ channels.
A powerful alternative pharmacological strategy is to target elements in the putative signaling cascade linking the receptor to the ion channel, in this case the L-type Ca 2ϩ channel. In the brain, as well as other tissues, 5-HT 2 receptor activation stimulates PLC␤ isoforms and phosphoinositide (PI) hydrolysis (Berridge et al. 1983; Conn and Sanders-Bush 1984, 1986; Roth et al. 1984 Roth et al. , 1986 Sanders-Bush and Conn 1986 ). be mediated by the G protein, G ␣q (Goppelt-Struebe and Stroebel 1998; Jope et al. 1994; Shah et al. 1999; Wang and Friedman 1999) . The experiments described in the following text were designed to test the hypothesis that 5-HT 2 receptors modulate L-type Ca 2ϩ channels through this signaling pathway.
Disruption of G ␣q interactions blocks 5-HT 2 -mediated inhibition of L-type Ca 2ϩ current
To determine whether inhibition of L-type Ca 2ϩ current requires activation of G ␣q proteins, PPNs were dialyzed with a peptide designed to mimic its carboxyl-terminal docking site (Akhter et al. 1998 ). An excess of this peptide should prevent the agonist-bound 5-HT 2 receptors from binding and activating G ␣q proteins. In these experiments, control measurements were taken from PPNs dialyzed with a nonsense peptide (100 M) of equal size (Fig. 6A) . The traces in Fig. 6B show that introduction of the G q peptide (100 M) results in a blockade of the DOI-mediated inhibition of tail current. Figure 6C summarizes these experiments, showing that the G q peptide significantly reduces the DOI-mediated inhibition of L-type tail current (median ϭ 0%) when compared with control neurons dialyzed with the nonsense peptide (median ϭ17%; Kruskal-Wallis ANOVA, P Ͻ 0.01, n ϭ 10). In fact, in 50% of the neurons dialyzed with the G q peptide, the DOI-mediated inhibition of L-type tail current was completely abolished. FIG. 4. Bay K 8644 reveals that DOI suppresses L-type channel tail currents. A: the deactivation of the L-type tail current is dramatically slowed by the application of the L-channel agonist Bay K 8644 (1 M). Currents were evoked by stepping the voltage from the holding potential of Ϫ80 to Ϫ10 mV for 20 ms and then to Ϫ60 mV (see inset protocol). B: semi-log plot of absolute tail currents from before (A) and after Bay K 8644 application. Prior to Bay K 8644, the tail currents were fit with a single exponential having a time constant of 0.46 ms; after application, a second time constant was evident having a value of 6.3 ms. C: the amplitude of the Bay K 8644-induced L-type tail current, sampled every 5 s, is plotted to show the kinetics of the DOI-mediated (10 M) inhibition. D: the control trace shows the current evoked by stepping the voltage from the holding potential of Ϫ80 to Ϫ10 mV for 20 ms and then to Ϫ60 mV. Measurements of tail current amplitude are taken at the point where the control current completely decays (vertical bar). The DOI (10 M) trace shows the 5-HT 2 -mediated inhibition of the Bay K 8644-induced L-type tail current. This inhibition is clearly seen in the magnification box to the right. E: semi-log plot of absolute tail currents before and after DOI application. Both currents were well-fit with a bi-exponential function having a fast time constant of 0.60 ms and a slow time constant of 6.87 ms. The slow component is plotted for both tail currents. The amplitude of the slow component was reduced from 2.56 to 2.11 nA by DOI (18%), whereas the fast component was reduced by only 7%. F: the data summarized in the box plot show the percent inhibition of L-type tail current by DOI (10 M) or ␣-m-5-HT (10 M; n ϭ 10).
PPNs coexpress PLC␤1 and PLC␤4 mRNAs
There are four known isoforms of PLC␤ that are expressed in the brain (PLC␤1-4) (Exton 1996) . PCR profiling revealed that pooled PFC cDNA contains mRNA for all PLC␤ isoforms (Fig. 7A, top left) . All of the PPNs examined with scRT-PCR techniques had detectable levels of PLC␤1 mRNA (n ϭ 8; Fig.  7A, top right) . Half of this sample also had detectable levels of PLC␤4 mRNA. None of the individual neurons profiled had detectable levels of PLC␤2 or PLC␤3 mRNA.
PLC␤ activation is required for 5-HT 2 -mediated inhibition of L-type Ca 2ϩ current
To determine if DOI inhibits L-type tail currents by stimulating PLC␤1 or PLC␤4, L-type tail currents were isolated and PLC activity was blocked. In these experiments, constitutive protein kinase C (PKC) activity was inhibited with chelerythrine chloride (1 M). Although inhibition of PKC activity reduced Ca 2ϩ channel currents (data not shown), it did not block the modulation of L-type currents by DOI. Co-perfusion of the PLC blocker U-73122 (200 nM) significantly reduced the ability of DOI to inhibit L-type tail currents (Fig. 7B) . The median percent inhibition of L-type current by DOI was 17% in the presence of chelerythrine chloride alone and 0% when U-73122 was co-perfused (Kruskal-Wallis ANOVA, P Ͻ 0.01, n ϭ 6). The DOI modulation in the presence of the weak PLC inhibitor U-73343 (200 nM) was not significantly different from that seen in control recordings (Kruskal-Wallis ANOVA, P Ͼ 0.05, n ϭ 5, Fig. 7B ).
FIG. 5. 5-HT 1 receptor stimulation inhibits aggregate HVA current but not L-type tail current. A: currents were evoked by stepping the voltage from the holding potential of Ϫ80 to Ϫ10 mV for 20 ms and then to Ϫ60 mV. Aggregate peak current was measured near the end of the step to Ϫ10 mV (E) and compared with Bay K 8644-evoked tail current from the same cell (•). The time course shows that while the 5-HT 1 agonist 8-OH-DPAT (1 M and 10 M) reversibly inhibited peak current it had no effect on the L-type tail current (n ϭ 7) in cells where DOI (10 M) inhibited L-type tail current (n ϭ 7). B: representative current traces from the experiment shown in A further demonstrate that the effect of 5-HT 1 receptor stimulation with (R)-(ϩ)-2-(dipropylamino)-8-hydroxy-1,2,3,4-tetrahydronaphthalene (8-OH-DPAT, 10 M) is limited to a reduction in peak current. FIG. 6. Blocking 5-HT 2 receptor interaction with G q proteins attenuates 5-HT 2 -mediated inhibition of L-type current. A: DOI (10 M) inhibits L-type tail current in PPNs dialyzed with a nonsense peptide control (100 M). B: the DOI-mediated inhibition is reduced in PPNs dialyzed with a with a G q peptide (100 M) designed to block docking of G ␣q to the 5-HT 2 receptor. C: the box plot summarizes the data, showing that dialyzing PPNs with a G q peptide (100 M) reduces or completely blocks the DOI-mediated inhibition of the L-type tail current when compared with the nonsense peptide controls (P Ͻ 0.01, n ϭ 10).
5-HT 2 -mediated inhibition of L-type Ca 2ϩ current requires release of Ca 2ϩ from intracellular stores
Activation of PLC is known to stimulate PI hydrolysis, IP3 production, and liberation of Ca 2ϩ from endoplasmic reticulum (ER) stores. In parallel, PLC increases 1,2-diacylglycerol (DAG) levels leading to activation of PKC. The failure of the PKC inhibitor chelerythrine chloride to block the 5-HT 2 -mediated inhibition of L-type current implicates the IP3 limb of the signaling cascade. The next set of experiments tests this hypothesis.
If release of Ca 2ϩ from intracellular stores is a critical step in the modulation, then it should be attenuated by depletion of these stores. To accomplish this, neurons were exposed to the Ca 2ϩ pump blocker thapsigargin (5 M). As shown in Fig. 8 , thapsigargin markedly attenuated the ability of DOI to modulate Bay-K-8644-enhanced tail currents; records prior to (Fig.  8A ) and after thapsigargin treatment (Fig. 8B ) are shown. Because thapsigargin elevates cytosolic Ca 2ϩ levels by disrupting sequestration (Thastrup et al. 1990) , the reduction in the slow tail currents revealed by the time-course plot (Fig. 8C) is expected of a Ca 2ϩ -dependent modulation. The data are summarized in Fig. 8D . Thapsigargin treatment significantly reduced the median inhibition of L-type current from 23 to 3% (Kruskal-Wallis ANOVA, P Ͻ 0.01, n ϭ 5).
To test whether the DOI-mediated effect on tail currents required IP3-mediated release of Ca 2ϩ from intracellular stores, PPNs were perfused with xestospongin C (1 M), a specific blocker of IP3-mediated Ca 2ϩ release (Gafni et al. 1997) . Xestospongin significantly reduced the DOI-mediated inhibition of L-type tail current (Kruskal-Wallis ANOVA, P Ͻ 0.02, n ϭ 4; Fig. 8E ). The median DOI inhibition of L-type tail current was 18% prior to xestospongin exposure and 4% after.
If an elevation in intracellular Ca 2ϩ concentration is necessary for the DOI-mediated reduction of L-type tail current, chelation of intracellular Ca 2ϩ should reduce the modulation. To test this prediction, neurons were dialyzed with a high concentration of the fast Ca 2ϩ chelator BAPTA (15 mM). The first set of traces in Fig. 9A show the typical DOI-mediated inhibition of L-type current in the absence of chelator. The next records (Fig. 9B) show that this inhibition is reduced by dialysis with BAPTA. These experiments are summarized in Fig.  9C . The median percent DOI inhibition of L-type current was 20% in controls (n ϭ 10) and 10% in neurons dialyzed with high BAPTA (n ϭ 7). Kruskal-Wallis ANOVA confirmed that the BAPTA reduction of the DOI-mediated inhibition of L-type tail current was significant (P Ͻ 0.001). The ␣-m-5-HT-mediated reduction of L-type tail current also was examined for sensitivity to Ca 2ϩ chelation. Like DOI, neurons dialyzed with BAPTA show significantly less modulation by ␣-m-5-HT. In these experiments, the median percent of ␣-m-5-HT inhibition was 27% in the controls and 10% in neurons dialyzed with high BAPTA (Kruskal-Wallis ANOVA, P Ͻ 0.05, n ϭ 5). The fact that high concentrations of BAPTA were less effective than thapsigargin or zestospongin in reducing the DOI/␣-m-5-HT modulation is not surprising given its hydrophilicity and potentially limited subcellular distribution.
5-HT 2 -mediated inhibition of L-type Ca 2ϩ current requires activation of calcineurin

Elevations in intracellular Ca
2ϩ have been shown to reduce L-type Ca 2ϩ currents by activation of the Ca 2ϩ -dependent phosphatase calcineurin (Chad and Eckert 1986; Lukyanetz et al. 1998a; Schuhmann et al. 1997) . To determine whether a similar mechanism was mediating the 5-HT 2 receptor modulation, calcineurin activity was blocked by dialysis with the calcineurin autoinhibitory peptide (10 M) (Hashimoto et al. 1990 ). Recordings taken from control PPNs (Fig. 10A) were compared with those from neurons dialyzed with the calcineurin autoinhibitory peptide (Fig.  10B ). This peptide significantly reduced the median DOI inhibition of L-type tail current from 20 to 8% (KruskalWallis ANOVA, P Ͻ 0.001, n ϭ 7; Fig. 10D ). As an additional test, neurons were treated with the membrane permeable calcineurin inhibitor FK-506 (1 M) (McCall et al. 1996; Raufman et al. 1996) . FK-506 also decreased the ability of DOI to inhibit tail current (Fig. 10C) . The median inhibition of L-type Ca 2ϩ current was dramatically reduced to 0% by FK-506 preincubation ( Fig. 10D ; Kruskal-Wallis ANOVA, P Ͻ 0.001, n ϭ 7). al. 2000). Ca v 1.2 channels are found primarily in the soma and proximal dendrites, whereas Ca v 1.3 channels have a more diffuse distribution (Hell et al. 1993) . Although both channel ␣1 subunits are phosphorylated by serine/threonine kinases (Hell et al. 1994) , the functional consequences of cardiac Ca v 1.2 channel phosphorylation and dephosphorylation are best understood (e.g., McHugh et al. 2000) . To determine if Ca v 1.2 channels are targeted by the 5-HT 2 receptor signaling pathway, the ability of DOI to modulate L-type currents was examined in neurons from Ca v 1.3 knockout mice (Platzer et al. 2000) . In these neurons, all of the L-type current is attributable to Ca v 1.2 channels. As shown in Fig. 11A , Ca v 1.2 channel currents activated at relatively hyperpolarized membrane potentials, having a threshold near Ϫ60 mV, a median half-activation voltage of Ϫ18 mV, and median slope factor of 7.5 (n ϭ 3). Bay K 8644-enhanced Ca v 1.2 tail currents were robustly modulated by application of DOI. A typical plot of peak tail current amplitude as a function of time is shown if Fig. 11B . Representative current traces showing the DOI induced reduction in tail currents is shown in Fig. 11C . The median modulation by DOI was 28% in Ca v 1.3 knockout PPNs and 29% in heterozygotes (Fig. 11D) . Although a role for Ca v 1.3 channels cannot be excluded, these results demonstrate that Ca v 1.2 Ca 2ϩ channels are prominent targets of 5-HT 2 receptor modulation in PPNs. FIG. 8. Depleting Ca 2ϩ or blocking inositol trisphosphate (IP3)-mediated release of Ca 2ϩ from intracellular stores reduces 5-HT 2 -mediated inhibition of L-type current. A: L-type tail current is evoked as before with Bay K 8644 (1 M) in the absence of external Ca 2ϩ and Ca 2ϩ chelators and the DOI-mediated inhibition is recorded. B: after the PPN is perfused with thapsigargin (5 M) and the current stabilizes, the DOI-mediated inhibition is markedly reduced. C: the time course of this experiment demonstrates 1st, a robust inhibition of L-type current by DOI (10 M), 2nd, temporal increases in cytosolic Ca 2ϩ caused by thapsigargin inhibit L-type current, and 3rd, subsequent application of DOI fails to further inhibit tail current. D: the box plot shows that application of DOI (10 M) inhibits the current significantly more prior to depletion of intracellular Ca 2ϩ stores with a 3-to 5-min application of thapsigargin (5 M; P Ͻ 0.01, n ϭ 5). E: this box plot shows that blocking IP3-mediated Ca 2ϩ release with xestospongin C (1 M) significantly reduces the DOI inhibition of L-type tail current when compared with control records taken prior to inhibitor treatment (P Ͻ 0.02, n ϭ 4).
Ca v 1.2 channels are targeted by the 5-HT 2 signaling cascade
D I S C U S S I O N
Deep-layer PPNs express 5-HT 2 receptor mRNAs
The 5-HT innervation of the rodent cortex arising from the raphe nuclei is diffuse and is found in all cortical layers. There are several classes of 5-HT receptor that transduce signals arising from this cortical innervation. The most prominent of these in the frontal cortex appear to be the 5-HT 1A , 5-HT 2A , and 5-HT 2C classes (Boess and Martin 1994) . Recently, 5-HT 2A receptors have been localized on the apical dendrite of layer III and V pyramidal neurons in the primate PFC (Goldman-Rakic 1999; Willins et al. 1997) . These receptors are also found in some interneurons (Vysokanov et al. 1998) . The expression of 5-HT 2A receptors by a substantial population of rat layer V-VI PPNs is consistent with our scRT-PCR profiling and suggests that the physiological effects described here are mediated primarily by 5-HT 2A receptors. Several lines of evidence implicate 5-HT 2 receptors in the modulation of L-type currents. First, as mentioned in the preceding text, 5-HT 2A receptors are expressed by these neurons. Second, 5-HT 2 receptor-selective agonists DOI and ␣-m-5-HT effectively modulated L-type currents. In contrast, activation of the other major 5-HT receptor population in these neurons-5-HT 1A receptors-was ineffective in modulating L-type currents, as in sensorimotor cortex pyramidal neurons (Foehring 1996) . The next logical step in verifying 5-HT 2 receptor involvement would have been to show selective antagonism. However, the application of 5-HT 2 receptor-specific antagonists reduced currents in the absence of receptor stimulation. Because these effects were qualitatively similar to those of the agonists, the change was not due to inverse agonism. Rather experiments examining the interaction of the antagonist effects with those of the nonspecific Ca 2ϩ channel blocker Cd 2ϩ suggested that much of the reduction in currents could be attributed to a direct channel block. Neuroleptics also block voltage-dependent Ca 2ϩ channels, albeit through what appeared to be an allosteric mechanism (Sah and Bean 1993) . More work will be required to cleanly delineate the mechanism by which the 5-HT antagonists are blocking Ca 2ϩ channels. Nevertheless, these direct actions precluded their use in confirming activation of 5-HT 2 receptors in the modulation of L-type Ca 2ϩ channel currents. As an alternative to receptor antagonism, the signaling elements mediating the agonist-induced modulation were characterized. These studies lend strong support to the proposition that the modulation was mediated by 5-HT 2 receptors. Biochemical studies have shown that cortical 5-HT 2 receptor regulation of intracellular events is dependent on coupling to the G protein G ␣q (Adlersberg et al. 2000) . Dialysis with a peptide FIG. 10. Blocking calcineurin activation attenuates 5-HT 2 -mediated inhibition of L-type current. A: a representative trace from a control set of recordings where L-type tail current was evoked as before with Bay K 8644 (1 M) and the DOI-mediated inhibition measured. B: the inhibition of tail current is reduced in a PPN dialyzed with calcineurin autoinhibitory peptide (50 M). C: preincubation with the calcineurin inhibitor FK-506 (1 M) blocks the inhibition of tail current by DOI (10 M) (P Ͻ 0.001, n ϭ 7). D: this box plot summarizes the effect of blocking calcineurin on the DOI-mediated inhibition of the tail current. First, dialyzing the neurons with the calcineurin autoinhibitory peptide (50 M) significantly reduces the inhibition of tail current by DOI (P Ͻ 0.001, n ϭ 7). Second, perfusion with the calcineurin inhibitor FK-506 (1 M) also reduces inhibition of tail current by DOI (P Ͻ 0.001, n ϭ 7). mime of the G ␣q docking domain (that should act as a competitive inhibitor of 5-HT 2 receptor coupling) significantly attenuated the DOI-mediated inhibition of L-type current, providing direct evidence for G ␣q involvement and 5-HT 2 receptor mediation. Even more compelling evidence for this conclusion came from subsequent experiments that delineated the signaling mechanism linking G ␣q proteins to L-type channels.
5-HT
G ␣q proteins stimulate PLC␤ isoforms, leading to the generation of IP3 and DAG (Exton 1997; Katan 1996; Taylor et al. 1991; Umemori et al. 1997) . scRT-PCR profiling revealed that PPNs co-express two PLC␤ isoform mRNAs (PLC␤1 and PLC␤4). Inhibition of these isoforms with U-73122 blocked the DOI-mediated reduction of L-type Ca 2ϩ current. DAG generated by PLC␤1/4 results in the activation of PKC isoforms (Tanaka and Nishizuka 1994) . However, this limb of the 5-HT 2 receptor signaling cascade did not appear to participate in the modulation of L-type channel currents as perfusion with the PKC inhibitor chelerythrine chloride did not alter the DOI effect. This was true in spite of the fact that PKC can suppress Ca v 1.2 channel currents in certain circumstances (McHugh et al. 2000) and that 5-HT 2 receptors activate PKC targeting Na Ca 2ϩ released from intracellular stores is known to activate the Ca 2ϩ -dependent phosphatase calcineurin (PP2B) in a variety of cell types (Hernandez-Lopez et al. 2000; Nishi et al. 1999; Yan et al. 1999) . Inhibition of calcineurin with either an autoinhibitory peptide or with FK-506 significantly attenuated the agonist-induced modulation of L-type tail currents. Calcineurin is also known to dephosphorylate skeletal (Ca v 1.1) and cardiac (Ca v 1.2) L-type Ca 2ϩ channels at serine residues leading to a reduction in macroscopic currents (Armstrong et al. 1991; Chad and Eckert 1986; Lukyanetz et al. 1998b; Schuhmann et al. 1997) . Although the phosphorylation sites critical to this reduction have not been definitively mapped, the PKA site at S1928 is a strong candidate (Gao et al. 1997) . PKA phosphorylation of Ca v 1.2 channels enhances open probability and macroscopic currents (Yue et al. 1990 ). The anchoring proteins necessary to support PKA modulation of Ca v 1.2 channels (AKAPs) also bind calcineurin, bringing both enzymes into close proximity to the channel complex (Coghlan et al. 1995; Klauck et al. 1996) . The demonstration that the 5-HT 2 receptor signaling cascade targets Ca v 1.2 channels suggests that a similar AKAP complex is present in PPNs. Our findings do not exclude the possibility that Ca 2ϩ released from intracellular stores directly interacts with the calmodulin-like do- main of the channel, further reducing currents (Imredy and Yue 1994; Peterson et al. 1999; Schuhmann et al. 1997) . However, the impact of calcineurin inhibitors on the modulation argue that this is not an important mechanism in the response to 5-HT.
Functional implications
In a variety of cell types, L-type Ca 2ϩ currents are important determinants of neuronal integration, synaptic plasticity, and gene expression. For example, entry of Ca 2ϩ specifically through L-type Ca 2ϩ channels has been linked to the induction of activity-dependent changes in gene expression in hippocampal pyramidal neurons (Bading et al. 1993; Boukhaddaoui et al. 2000; Mermelstein et al. 2000; Murphy et al. 1991) . Related mechanisms may mediate L-type channel involvement in certain forms of long-term synaptic potentiation and depression (Bolshakov and Siegelbaum 1994; Calabresi et al. 1994; Kapur et al. 1998) . At this point, the roles of Ca v 1.2 and Ca v 1.3 L-type channels in these processes have not been determined. In hippocampal and cortical pyramidal neurons, both channels are found not only at distal dendritic sites close to synapses but at perisomatic sites that have preferential access to Ca 2ϩ -dependent transcriptional regulators (Hell et al. 1993; ). This differential subcellular localization is particularly prominent for Ca v 1.2 channels. The modulation of these channels by 5-HT 2 receptors establishes a potential mechanism by which serotonin could regulate gene expression and long-term changes in PFC physiology. It also provides a means by which atypical neuroleptics could induce immediate early gene expression and longer term changes in PFC function (Robertson et al. 1994; Robertson and Fibiger 1996; Wiesel et al. 1994 ). However, the ostensibly direct action of clozapine and risperidone on L-type Ca 2ϩ channels makes it unclear whether the atypical neuroleptics are acting as 5-HT antagonists or 5-HT mimes.
In addition to regulating long-term changes in excitability, Ca 2ϩ entry through L-type channels influences short-term integration of synaptic input. For example, dendritic L-type Ca 2ϩ channels are thought to make a significant contribution to the nonlinear integration of strong excitatory synaptic input to pyramidal neurons (Kim and Connors 1993; Larkum et al. 1999; Magee et al. 1998; Schiller et al. 1997) . This contribution may be particularly important in the amplification of NMDA receptor currents and prolongation of synaptically triggered dendritic depolarization (Cepeda et al. 1998; Dudek and Fields 2001; Hernandez-Lopez et al. 1997) . Even a modest (10 -20%) suppression of these regenerative currents could have profound effects on these nonlinear dendritic events. In fact, activation of 5-HT 2 receptors in PPNs does lead to a suppression of NMDA receptor-mediated currents (Arvanov et al. 1999a) , possibly through suppression of boosting L-channel currents. The 5-HT 2 receptor suppression of L-type currents may also narrow the temporal window through which backpropagating action potentials can influence orthodromically conducted events and burst generation (Larkum et al. 1999; Schiller et al. 1995; Stuart et al. 1997; Svoboda et al. 1997) .
